Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas.

Michael N PassarelliE L BarryD ZhangP GangarJ R ReesR S BresalierG McKeown-EyssenM R KaragasJ A Baron

Published in: The British journal of dermatology (2018)

Neither aspirin nor folic acid treatment had a statistically significant effect on risk of BCC. Subgroup analysis suggested that chemopreventive effects of nonsteroidal anti-inflammatory drugs may be specific to those at high risk for BCC.

Keyphrases

anti inflammatory drugs
basal cell carcinoma
low dose
cardiovascular events
antiplatelet therapy
type diabetes
randomized controlled trial
coronary artery disease
atrial fibrillation